Carriel Nipp, MD
Interventional Cardiology · Lake Charles, LANPI 1184165326
Payments from drug & device makers
Across 80 payments — averaging $180.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Edwards Lifesciences$2K
- Abbott$2K
- Boston Scientific$588
- Abiomed$407
- Shockwave Medical, Inc$221
- plus $808 from 12 others
What the payments were for
- Grants$8,00055%
- Travel & lodging$1,76512%
- Food & beverage$3,70626%
- Education$9727%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $8,738 |
| Edwards Lifesciences | 18 | $1,896 |
| Abbott | 14 | $1,786 |
| Boston Scientific | 4 | $588 |
| Abiomed | 9 | $407 |
| Shockwave Medical, Inc | 3 | $221 |
| AstraZeneca | 3 | $206 |
| Heartflow, Inc. | 1 | $146 |
| Angiodynamics, Inc. | 1 | $83 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $73 |
| Chiesi USA, Inc. | 1 | $72 |
| Novartis | 3 | $57 |
| Asahi Intecc USA, Inc. | 1 | $50 |
| Terumo Medical Corporation | 1 | $38 |
| Amgen | 2 | $35 |
| Cleerly, Inc. | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$839
- Edwards SAPIEN 3 Transcatheter Heart Valve$335
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$269
- COREVALVE EVOLUT R$253
- QUADRA ASSURA$224
- RESOLUTE ONYX$214
- ONYX FRONTIER$164
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$151
- FFRct$146
- Impella$145
- AVVIGO Guidance System$144
- SAPIEN 3 Ultra RESILIA$119
- Diamondback Coronary$104
How this compares
$14,444 in reported general payments places this provider in the 55th percentile of 171 interventional cardiology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $9,289 |
| EliquisApixaban | 15 | $9,060 |
| Rosuvastatin Calcium | 37 | $439 |
| Metoprolol Succinate | 36 | $327 |
| ClopidogrelClopidogrel Bisulfate | 27 | $211 |
| Atorvastatin Calcium | 29 | $204 |
| Losartan Potassium | 29 | $190 |
| Carvedilol | 18 | $151 |
| Amlodipine Besylate | 31 | $141 |
| Spironolactone | 16 | $127 |
| Furosemide | 14 | $96 |
| Nitroglycerin | 11 | $96 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Lake Charles
- Craig WalkerHouma$5.5M
- Naseem JaffraniAlexandria$5.1M
- Mark NapoliMonroe$2.2M
- Stephen RameeNew Orleans$1.5M
- Denzil MoraesBaton Rouge$1.4M
- James JenkinsNew Orleans$1.2M
- Ankur LodhaLafayette$945K
- Rajan PatelNew Orleans$633K
- Bruce EnnisMandeville$562K
- Jorge CastellanosBaton Rouge$561K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.